Such “humanized” mice were inoculated with syngeneic MC38 cells as described in our recent publication to investigate the role of gut microbiota in anti-PD-1 therapy (Figure 1a).6 As shown in Figure 1b, anti-PD-1 differently influenced tumor progression in an individual group of mice. Here, PDCD1 is linked to neoplasm.